Serum p53 antibodies in patients with oral lesions: Correlation with p53/HSP70 complexes

International Journal of Cancer

Volumn 74, Issue 6, 1997, Pages 609-613

  Kaur, Jasbir ^a   Srivastava, Anurag ^a   Ralhan, Ranju ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

HEAT SHOCK PROTEIN; PROTEIN P53;

ADULT; AGED; ANTIBODY DETECTION; ARTICLE; CANCER SURVIVAL; CLINICAL ARTICLE; FEMALE; HEAD AND NECK CARCINOMA; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MALE; MOUTH CARCINOMA; PRIORITY JOURNAL; PROGNOSIS; SQUAMOUS CELL CARCINOMA;

ADULT; AGED; ANTIBODIES, NEOPLASM; AUTOANTIBODIES; CARCINOMA, SQUAMOUS CELL; FEMALE; FOLLOW-UP STUDIES; HSP70 HEAT-SHOCK PROTEINS; HUMANS; MALE; MIDDLE AGED; MOUTH NEOPLASMS; PRECANCEROUS CONDITIONS; TUMOR SUPPRESSOR PROTEIN P53;

EID: 0031443271     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(19971219)74:6<609::AID-IJC9>3.0.CO;2-Y     Document Type: Article

References (20)

1. BOURIS, J. and 12 OTHERS, Analysis of p53 serum antibodies in patients with head-and-neck squamous-cell carcinoma. J. nat. Cancer Inst., 88, 1228-1233 (1996).
2. BURNS, J.E., BAIRD, M.C., CLARK, L.J., BURNS, P.A., EDINGTON, K., CHAPMAN, C., MITCHELL, R., ROBERTSON, G., SOUTAR, D. and PARKINSON, E.K., Gene mutations and increased levels of p53 protein in human squamous-cell carcinomas and their cell lines. Brit. J. Cancer, 67, 1274-1284 (1993).
3. CARON DE FROMENTEL, C., NARDEUX, P.C., SOUSSI, T., LAVIALLE, C., ESTRADE, S., CARLONI, G., CHANDRASEKARAN, K. and CASSINGENA, R., Epithelial HBL-100 cell line derived from milk of an apparently healthy woman harbours SV40 genetic information. Exp. Cell Res., 160, 83-94 (1985).
4. CRAWFORD, L.V., PIM, D.C. and BULBROOK, R.D., Detection of antibodies against the cellular protein p53 in sera from patients with breast cancer. Int. J. Cancer, 89, 403-408 (1982).
5. DAVIDOFF, A.M., IGLEHART, J.D. and MARKS, J.R., Immune response to p53 is dependent upon p53/HSP70 complexes in breast cancers. Proc. nat. Acad. Sci. (Wash.), 89, 3439-3442 (1992).
6. GREENBLATT, M.S., BENNETT, W.P., HOLLSTEIN, M. and HARRIS, C.C., Mutations in p53 tumor-suppressor gene: clues to cancer etiology and molecular pathogenesis. Cancer Res., 54, 4855-1878 (1994).
7. HINDS, P.W., FINLAY, C.A., QUARTIN, R.S., BAKER, S.J., FEARON, E.R., VOGELSTEIN, B. and LEVINE, A.J., Mutant p53 DNA clones from human colon carcinomas cooperate with ran in transforming primary rat cells: a comparison of the "hot spots" mutant phenotypes. Cell Growth Differ., 1, 571-580 (1990).
8. HOUBIERS, J.G.A., VANDER BURG, S.H., VANDE DE WATERING, L.M.G., TOLLENAAR, R.A.E.M., BRAND, A., VANDER VELDE, J.H. and MELIEF, C.J.M., Antibodies against p53 are associated with poor prognosis of colorectal cancer. Brit. J. Cancer, 72, 637-641 (1995).
9. KAUR, J. and RALHAN, R., Differential expression of 70-kDa heat-shock protein in human oral tumorigenesis. Int. J. Cancer, 63, 774-779 (1995).
10. KAUR, J., SRIVASTAVA, A. and RALHAN, R., Over-expression of p53 protein in betel- and tobacco-related human oral dysplasia and squamous-cell carcinoma in India. Int. J. Cancer, 58, 340-345 (1994).
11. KAUR, J., SRIVASTAVA, A. and RALHAN, R., p53-HSP70 complexes in oral dysplasia and cancer: potential prognostic implications. Oral Oncol. Europ. J. Cancer, 32B, 45-49 (1996).
12. LAURENT-PUIG, P., LUBIN, R., SEMHOUN-DUCLOUX, S., PELLETIER, G., FOURRE, C., DUCREUX, M., BRIANTAIS, M.J., BUFFET, C. and SOUSSI, T., Antibodies against p53 protein in serum of patients with benign or malignant pancreatic and billiary disease. Gut, 36, 455-458 (1995).
13. LAVIEILLE, J.P., LUBIN, R., SOUSSI, T., REYT, E., BRAMBILLA, C. and RIVA, C., Analysis of p53-antibody-response patients with squamous-eell carcinoma of the head and neck. Anticancer Res., 16, 2385-2388 (1996).
14. LUBIN, R. and 19 OTHERS, Analysis of p53 antibodies in patients with various cancers define B-cell epitopes of human p53 mutation: distribution on primary structure and exposure on protein surface. Cancer Res., 53, 5872-5876 (1993).
15. LUBIN, R., ZALCMAN, G., BOUCHET, L., TREDANIEL, J., LEGROS, Y., CAZALS, D., HIRSCH, A. and SOUSSI, T., Serum p53 antibodies as early markers of lung cancer. Nature Med., 1, 701-702 (1995).
16. MUNIRAJAN, A.K., TUTSUMI-ISHI, Y., MOHANPRASAD, B.K.C., HIRANO, Y., MUNAKATA, N., SHANMUGAM, G. and TSUCHIDA, N., p53-gene mutations in oral carcinomas from India. Int. J. Cancer, 66, 297-300 (1996).
17. RAYBAUD-DIOGÈNE, H., TETU, B., MORENCY, R., FORTIN, A. and MONTEIL, R.A., p53 over-expression in head-and-neck squamous-cell carcinoma: review of the literature. Oral Oncol. Europ. J. Cancer, 32B, 143-149 (1996).
18. SCHLICHTHOLZ, B., LEGROS, Y., GILLET, D., GAILLARD, C., MARTY, M., LANE, D., CALVO, F. and SOUSSI, T., The immune response to p53 in breast-cancer patients is directed against immunodominant epitopes unrelated to the mutational hot spot. Cancer Res., 52, 6380-6384 (1992).
19. SRIVASTAVA, P.K., Heat-shock protein in immune response to cancer: The fourth paradigm. Experientia, 50, 1054-1060 (1994).
20. VAN BUSKIRK, A.M., DENAGEL, D.C., GUAGLIARDI, L.E., BRODSKY, F.M. and PIERCE, S.K., Cellular and subcellular distribution of PBP72/74, a peptide-binding protein that plays a role in antigen processing. J. Immunol., 146, 500-506 (1991).